PRELUDE CAPITAL MANAGEMENT, LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 110 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$2,000
-60.0%
4860.0%0.00%
Q3 2018$5,0000.0%486
-21.9%
0.00%
Q2 2018$5,0000.0%622
-26.0%
0.00%
Q1 2018$5,000
-16.7%
840
+32.1%
0.00%
Q4 2017$6,000
-33.3%
636
-32.5%
0.00%
-100.0%
Q3 2017$9,000
-30.8%
942
-9.8%
0.00%0.0%
Q2 2017$13,000
-45.8%
1,044
-59.8%
0.00%
-66.7%
Q4 2016$24,000
-52.0%
2,600
-38.1%
0.00%
-40.0%
Q3 2016$50,000
-16.7%
4,200
+100.0%
0.01%
-44.4%
Q4 2015$60,000
+62.2%
2,100
+61.5%
0.01%
+80.0%
Q3 2015$37,000
-50.7%
1,300
-38.1%
0.01%
-50.0%
Q2 2015$75,000
+59.6%
2,100
+162.5%
0.01%
+42.9%
Q1 2015$47,000
-67.1%
800
-76.5%
0.01%
-66.7%
Q4 2014$143,000
+8.3%
3,4000.0%0.02%
+10.5%
Q3 2014$132,000
-15.4%
3,400
-32.0%
0.02%
-9.5%
Q2 2014$156,0005,0000.02%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2018
NameSharesValueWeighting ↓
Raging Capital Management, LLC 295,790$1,367,0000.20%
Jump Trading, LLC 42,400$196,0000.06%
GAM Holding AG 83,940$388,0000.02%
Magnus Financial Group LLC 13,393$62,0000.01%
PANAGORA ASSET MANAGEMENT INC 438,606$2,026,0000.01%
Quantamental Technologies LLC 3,898$18,0000.01%
QS Investors, LLC 155,683$719,0000.01%
SFMG, LLC 11,994$55,0000.01%
Winslow, Evans & Crocker, Inc. 4,060$20,0000.01%
MILLENNIUM MANAGEMENT LLC 812,262$3,753,0000.01%
View complete list of INSYS THERAPEUTICS INC NEW shareholders